Abstract | BACKGROUND: METHODS: In our center, we retrospectively analyzed the data of hospitalized macrolide-unresponsive Mp pneumonia patients aged ≤18 years old who changed macrolide therapies to minocycline treatments between March 2013 and September 2018. Patient characteristics and defervescence after minocycline treatment were compared between refractory Mp pneumonia and non-refractory Mp pneumonia groups. Multivariable logistic regression analysis was performed among these macrolide-unresponsive Mp pneumonia patients. RESULTS: Among 150 included macrolide-unresponsive Mp pneumonia children treated with minocycline; 30 cases (20.0%) were refractory Mp pneumonia. Duration of macrolide treatment before administration of minocycline (odds ratio =2.87, 95% CI: 1.79-4.61, P<0.001) and serum procalcitonin levels (odds ratio =13.50, 95% CI: 1.22-149.57, P=0.034) were independently associated with refractory Mp pneumonia. Defervescence after minocycline treatment was significantly longer among the refractory Mp pneumonia group than in the non-refractory Mp pneumonia group (median 2 vs. 1 day, P<0.001). Only one case (0.7%) suspected of a side effect of minocycline therapy was observed. CONCLUSIONS:
|
Authors | Jiande Chen, Xinyi Qi, Yong Yin, Lei Zhang, Jing Zhang, Shuhua Yuan |
Journal | Translational pediatrics
(Transl Pediatr)
Vol. 10
Issue 11
Pg. 2997-3004
(Nov 2021)
ISSN: 2224-4344 [Print] China |
PMID | 34976765
(Publication Type: Journal Article)
|
Copyright | 2021 Translational Pediatrics. All rights reserved. |